Literature DB >> 22329114

Illicit bath salts: not for bathing.

Patrick B Kyle1, Richard B Iverson, Raghavendran G Gajagowni, Lee Spencer.   

Abstract

BACKGROUND: There has been an increase in the popularity of designer drugs known as "Bath Salts" in the United States. These products commonly contain mephedrone, mephylone, methylenedioxypyrovalerone (MDPV), or other cathinone derivatives with psychoactive properties similar to amphetamine and cocaine. Although recently outlawed, abuse of these products continues to occur in Mississippi.
METHODS: We report a 19-year-old male who presented with paranoia and auditory as well as visual hallucinations. Auditory effects included voices that prompted him to kill people. The patient displayed anxiety, paranoia, and exhibited repeated bouts of inappropriate laughter. Urine toxicology analysis via GC/ MS detected MDPV, a compound structurally similar to methylenedioxymethamphetamine (MDMA).
CONCLUSIONS: Clinicians should be aware that these designer drugs are not detected with common immunoassay drug screens. Symptoms most commonly associated with these substances include tachycardia, delusions, hallucinations, and paranoia. Psychosis, self harm, and death have been associated with some cases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22329114

Source DB:  PubMed          Journal:  J Miss State Med Assoc        ISSN: 0026-6396


  17 in total

1.  Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats.

Authors:  Pai-Kai Huang; Shawn M Aarde; Deepshikha Angrish; Karen L Houseknecht; Tobin J Dickerson; Michael A Taffe
Journal:  Drug Alcohol Depend       Date:  2012-06-03       Impact factor: 4.492

2.  "Bath salts"-induced psychosis in a young woman.

Authors:  Sadaf Khan; Farhat Shaheen; Hina Sarwar; Jules Molina; Saira Mushtaq
Journal:  Prim Care Companion CNS Disord       Date:  2013

3.  Are "bath salts" on your differential list? A case report of delirium and agitation after use of illicit bath salts.

Authors:  Roopa Sethi; Sachinder Vasudeva
Journal:  Prim Care Companion CNS Disord       Date:  2013

Review 4.  Synthetic cathinones ("bath salts").

Authors:  Matthew L Banks; Travis J Worst; Daniel E Rusyniak; Jon E Sprague
Journal:  J Emerg Med       Date:  2014-02-22       Impact factor: 1.484

5.  Relative reinforcing effects of second-generation synthetic cathinones: Acquisition of self-administration and fixed ratio dose-response curves in rats.

Authors:  Brenda M Gannon; Kayla I Galindo; Melson P Mesmin; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Neuropharmacology       Date:  2017-08-12       Impact factor: 5.250

6.  Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice.

Authors:  Brenda M Gannon; Lauren N Russell; Meet S Modi; Kenner C Rice; William E Fantegrossi
Journal:  Drug Alcohol Depend       Date:  2017-08-04       Impact factor: 4.492

7.  Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.

Authors:  Michael H Baumann; John S Partilla; Kurt R Lehner; Eric B Thorndike; Alexander F Hoffman; Marion Holy; Richard B Rothman; Steven R Goldberg; Carl R Lupica; Harald H Sitte; Simon D Brandt; Srihari R Tella; Nicholas V Cozzi; Charles W Schindler
Journal:  Neuropsychopharmacology       Date:  2012-10-17       Impact factor: 7.853

8.  In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity.

Authors:  William E Fantegrossi; Brenda M Gannon; Sarah M Zimmerman; Kenner C Rice
Journal:  Neuropsychopharmacology       Date:  2012-11-08       Impact factor: 7.853

9.  Role of monoaminergic systems and ambient temperature in bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV)-elicited hyperthermia and locomotor stimulation in mice.

Authors:  Brenda M Gannon; Adrian Williamson; Kenner C Rice; William E Fantegrossi
Journal:  Neuropharmacology       Date:  2017-09-05       Impact factor: 5.250

Review 10.  Psychoactive "bath salts": not so soothing.

Authors:  Michael H Baumann; John S Partilla; Kurt R Lehner
Journal:  Eur J Pharmacol       Date:  2012-11-23       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.